> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Comments Sought on Scheduling for 8 Drugs
- URL: https://www.fdaweb.com/comments-sought-on-scheduling-for-8-drugs/
- Published: 2024-08-14T12:00:00.000Z
- Updated: 2026-09-14T14:38:14.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157568

*Federal Register* notice: FDA is seeking comments by 8/23 on the abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on medical use availability for eight drug substances. The comments will be considered in preparing a response to the World Health Organization about the abuse liability and diversion of the drugs so it can consider whether to recommend certain international restrictions that can be placed on them. The drugs are:

- Hexahydrocannabinol, a semi-synthetic cannabinoid.
- N-Pyrrolidino protonitazene, a synthetic opioid of the nitazene family
- N-Pyrrolidino metonitazene, a synthetic opioid of the nitazene family
- N-Piperidynyl etonitazene, a synthetic opioid of the nitazene family
- N-Desethyl-isotonitazene, a synthetic opioid of the nitazene family
- 3-Hydroxy-phencyclidine, a dissociative hallucinogen of the arylcyclohexylamine class
- N-Ethylheptedrone, a stimulant from the substituted cathinone drug class
- Carisoprodol, a sedative-hypnotic

To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-08-14/pdf/2024-18045.pdf?ref=fdaweb.com).